Endosonography vs Conventional Bronchoscopy for the Diagnosis of Sarcoidosis The GRANULOMA Randomized Clinical Trial

Carregando...
Imagem de Miniatura
Citações na Scopus
193
Tipo de produção
article
Data de publicação
2013
Editora
AMER MEDICAL ASSOC
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autores
BARTHELD, Martin B. von
DEKKERS, Olaf M.
SZLUBOWSKI, Artur
EBERHARDT, Ralf
HERTH, Felix J.
VEEN, Johannes C. C. M. in't
JONG, Ynze P. de
HEIJDEN, Erik H. F. M. van der
TOURNOY, Kurt G.
CLAUSSEN, Martin
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, v.309, n.23, p.2457-2464, 2013
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Importance Tissue verification of noncaseating granulomas is recommended for the diagnosis of sarcoidosis. Bronchoscopy with transbronchial lung biopsies, the current diagnostic standard, has moderate sensitivity in assessing granulomas. Endosonography with intrathoracic nodal aspiration appears to be a promising diagnostic technique. Objective To evaluate the diagnostic yield of bronchoscopy vs endosonography in the diagnosis of stage I/II sarcoidosis. Design, Setting, and Patients Randomized clinical multicenter trial (14 centers in 6 countries) between March 2009 and November 2011 of 304 consecutive patients with suspected pulmonary sarcoidosis (stage I/II) in whom tissue confirmation of noncaseating granulomas was indicated. Interventions Either bronchoscopy with transbronchial and endobronchial lung biopsies or endosonography (esophageal or endobronchial ultrasonography) with aspiration of intrathoracic lymph nodes. All patients also underwent bronchoalveolar lavage. Main Outcomes and Measures The primary outcome was the diagnostic yield for detecting noncaseating granulomas in patients with a final diagnosis of sarcoidosis. The diagnosis was based on final clinical judgment by the treating physician, according to all available information (including findings from initial bronchoscopy or endosonography). Secondary outcomes were the complication rate in both groups and sensitivity and specificity of bronchoalveolar lavage in the diagnosis of sarcoidosis. Results A total of 149 patients were randomized to bronchoscopy and 155 to endosonography. Significantly more granulomas were detected at endosonography vs bronchoscopy (114 vs 72 patients; 74% vs 48%; P < .001). Diagnostic yield to detect granulomas for endosonography was 80%(95% CI, 73%-86%); for bronchoscopy, 53%(95% CI, 45%-61%) (P < .001). Two serious adverse events occurred in the bronchoscopy group and 1 in the endosonography group; all patients recovered completely. Sensitivity of the bronchoalveolar lavage for sarcoidosis based on CD4/CD8 ratio was54%(95% CI, 46%-62%) for flow cytometry and 24% (95% CI, 16%-34%) for cytospin analysis. Conclusion and Relevance Among patients with suspected stage I/II pulmonary sarcoidosis undergoing tissue confirmation, the use of endosonographic nodal aspiration compared with bronchoscopic biopsy resulted in greater diagnostic yield.
Palavras-chave
Referências
  1. Agarwal R, 2012, RESP MED, V106, P883, DOI 10.1016/j.rmed.2012.02.014
  2. Annema JT, 2005, EUR RESPIR J, V25, P405, DOI 10.1183/09031936.05.00098404
  3. Baughman RP, 2001, AM J RESP CRIT CARE, V164, P1885
  4. Bradley B, 2008, THORAX S5, V63, pv1
  5. Chee Alex, 2012, J Bronchology Interv Pulmonol, V19, P24, DOI 10.1097/LBR.0b013e3182442925
  6. Costabel U, 1999, EUR RESPIR J, V14, P735, DOI 10.1034/j.1399-3003.1999.14d02.x
  7. Costabel U, 2008, CURR OPIN PULM MED, V14, P455, DOI 10.1097/MCP.0b013e3283056a61
  8. Fritscher-Ravens A, 2011, ENDOSCOPY, V43, P955, DOI 10.1055/s-0031-1271110
  9. Haslam PL, 1999, EUR RESPIR J, V14, P245, DOI 10.1034/j.1399-3003.1999.14b01.x
  10. Heron M, 2008, CLIN IMMUNOL, V126, P338, DOI 10.1016/j.clim.2007.11.005
  11. Iannuzzi MC, 2011, JAMA-J AM MED ASSOC, V305, P391, DOI 10.1001/jama.2011.10
  12. Iannuzzi MC, 2007, NEW ENGL J MED, V357, P2153, DOI 10.1056/NEJMra071714
  13. Iwashita T, 2008, ENDOSCOPY, V40, P400, DOI 10.1055/s-2007-995593
  14. Kantrow SP, 1997, EUR RESPIR J, V10, P2716, DOI 10.1183/09031936.97.10122716
  15. Navani N, 2011, RESPIROLOGY, V16, P467, DOI 10.1111/j.1440-1843.2011.01933.x
  16. Oki M, 2012, J THORAC CARDIOV SUR, V143, P1324, DOI 10.1016/j.jtcvs.2012.01.040
  17. Rybicki BA, 1997, AM J EPIDEMIOL, V145, P234
  18. Swigris JJ, 2011, AM J RESP CRIT CARE, V183, P1524, DOI 10.1164/rccm.201010-1679OC
  19. Tournoy KG, 2010, EUR RESPIR J, V35, P1329, DOI 10.1183/09031936.00111509
  20. Tournoy KG, 2009, LUNG CANCER, V63, P45, DOI 10.1016/j.lungcan.2008.04.004
  21. Tremblay A, 2009, CHEST, V136, P340, DOI 10.1378/chest.08-2768
  22. Trisolini R, 2004, SARCOIDOSIS VASC DIF, V21, P147
  23. von Bartheld M, 2012, GASTROINTEST ENDOSC, V75, P1104, DOI 10.1016/j.gie.2012.01.002
  24. von Bartheld MB, 2010, ENDOSCOPY, V42, P213, DOI 10.1055/s-0029-1243890